India  

Balkrishna

Indian businessman, Scholar of Ayurveda

Balkrishna    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Balkrishna: Indian businessman, Scholar of Ayurveda
Balkrishna is an Indian billionaire businessman and chairman of the consumer goods company Patanjali Ayurved. He was reported by Forbes to have a net worth of US$2.3 billion as of May 2021. According to Ashish Kumar of Arya Samaj, Balkrishna has successfully established and managed a global business without a formal education.

0
shares
ShareTweetSavePostSend
 
Patanjali Case: SC quashes Baba Ramdev's apology, says be ready to face action| Oneindia [Video]

Patanjali Case: SC quashes Baba Ramdev's apology, says be ready to face action| Oneindia

On Wednesday, the Supreme Court unequivocally rejected the "unconditional apology" tendered by Baba Ramdev and Acharya Balkrishna regarding the deceptive advertisements linked to Patanjali's medicinal..

Credit: Oneindia     Duration: 02:26Published

You Might Like


SC appreciates 'marked improvement' in public apology by Ramdev, Balkrishna, Patanjali


IndiaTimes - Published

'Is apology same size as ads?': SC grills Ramdev, Balkrishna in Patanjali misleading advertisements case

A bench of Justices Hima Kohli and Ahsanuddin Amanullah asked their counsel to place the apology published in newspapers on record within two days
DNA - Published

Supreme Court says Patanjali apology in newspapers should be same size as its advertisements

Mukul Rohatgi, appearing for Ramdev, said that an apology has been published in newspapers. But the Supreme Court reprimanded him on why the apology was published yesterday only. The ​​SC deferred..
IndiaTimes - Published

Ramdev, aide say sorry to SC, offer to issue public apology

Baba Ramdev and his disciple Balkrishna appeared before the Supreme Court and admitted to giving misleading advertisements about Patanjali products, apologizing with folded hands. The court criticized..
IndiaTimes - Published

Patanjali's misleading ads case: Willing to tender public apology, yoga guru Ramdev, Balkrishna tell SC

Ramdev and Balkrishna have tendered an ''unconditional and unqualified apology'' before the apex court over advertisements issued by the firm making tall claims about the medicinal efficacy of its..
DNA - Published

Your apology not worth paper it's written on, SC tells Ramdev; slams Uttarakhand government

Supreme Court toughens stance on Baba Ramdev, Balkrishna, Patanjali Ayurved for misleading ads, rejecting apology. Justices criticize false statements, warn of consequences, and question Uttarakhand..
IndiaTimes - Published

Patanjali misleading ads case: SC refuses to accept apology offered by Ramdev and Balkrishna, warns them of...

The court told the Uttarakhand government that it is not going to let it free in the case relating to the misleading advertisements of Haridwar-based Patanjali Ayurved."All complaints were forwarded to..
DNA - Published

Ramdev tenders unconditional apology, seeks pardon from Supreme Court

Ramdev and his disciple Acharya Balkrishna on Tuesday tendered unconditional apology and sought pardon from the court. In an affidavit filed in apex court, both assured the court they would not repeat..
IndiaTimes - Published

'Lip service': Supreme Court refuses to accept Ramdev apology

SC Tuesday pulled up Patanjali Ayurved's co-founders Baba Ramdev and Acharya Balkrishna while hearing a case against them over misleading ads. Both were in court to face contempt proceedings and were..
IndiaTimes - Published

'Wondering why govt chose to keep its eyes shut ...': What SC said on Ramdev's misleading ads case

Yoga guru Ramdev came before the Supreme Court on Tuesday and apologised unconditionally for violating an injunction relating to false promotions of Patanjali's medicinal products. The bench granted..
IndiaTimes - Published

Patanjali Ayurved director submits apology for misleading advertisement to SC

The Supreme Court has received an apology from Acharya Balkrishna, the managing director of Patanjali Ayurved and an aide of yoga guru Ramdev, for the company's misleading claims regarding the..
DNA - Published